Recombinant Pichia pastoris AIM11 is a heterologous protein engineered for production in the methylotrophic yeast Pichia pastoris (syn. Komagataella phaffii). It corresponds to the mitochondrial protein AIM11 (Uniprot ID: C4R7Q4), which is implicated in the regulation of mitochondrial inheritance pathways . The recombinant form is typically expressed as a partial sequence (1–199 amino acids) and purified for research or industrial applications .
High Yield: Capable of producing recombinant proteins at titers exceeding 10 g/L under optimized bioreactor conditions .
Post-Translational Modifications: Supports folding and secretion pathways similar to mammalian systems, though glycosylation patterns differ (e.g., hypermannosylation) .
Cost-Effective: Uses methanol or alternative carbon sources (e.g., glycerol, ethanol) for induction, though methanol-free systems are emerging .
| Field | Application |
|---|---|
| Basic Research | Studying mitochondrial inheritance mechanisms in yeast models. |
| Biotechnology | Development of tools for mitochondrial DNA manipulation or replication. |
| Therapeutic Research | Exploring mitochondrial dysfunction in diseases (e.g., neurodegenerative disorders). |
KEGG: ppa:PAS_chr4_0381
AIM11 (Altered Inheritance of Mitochondria protein 11) is a 199-amino acid mitochondrial protein involved in mitochondrial inheritance and function. It contains characteristic hydrophobic domains and is expressed in Pichia pastoris as a model system due to P. pastoris's exceptional capacity for post-translational modifications and high protein yields. P. pastoris offers significant advantages over other expression systems, including strong folding efficiency, high cell density fermentation capabilities, and a mature secretion system for releasing proteins into the external environment via Kex2 as signal peptidase . The full amino acid sequence of AIM11 is:
MRILLIFFVPSGILDQLFPRISILSTLRVNLTNSPLLTPNLTLYSMVNGFDFSKMFGRKDPELVSKEVKQYNERRFKQMALFYGFTVATFICSKIAYRGVIKRRYVPNYYQHNHVAPPFSFYRDALSAVFHSTSLAITSLGMASTGVLWYYDISSVAEFSFKLKQALGGHDKEQELKKLPEDETVQEIQNSINSYLGDR
P. pastoris offers several advantages over other yeast expression systems like Saccharomyces cerevisiae when expressing proteins such as AIM11:
Higher protein expression levels - P. pastoris can achieve protein titers exceeding 10 g/L, equivalent to 30% of total cell proteins, driven by the AOX1 promoter
Superior growth characteristics - P. pastoris can grow to extremely high cell densities (>150 g dry cell weight/liter) in simple media
Enhanced genetic stability - P. pastoris maintains stable expression over many generations
Efficient secretory pathway - The limited production of endogenous secretory proteins simplifies purification of target proteins
More human-like post-translational modifications compared to S. cerevisiae
Separation of protein induction phase from cell growth phase, allowing for optimized bioprocess design
The expression vector selection significantly impacts AIM11 production efficiency in P. pastoris. Key considerations include:
Promoter selection: The AOX1 (alcohol oxidase) promoter is commonly used but requires methanol induction, which has drawbacks including toxicity and flammability. Alternative promoters like GAP (constitutive) or novel synthetic promoters may offer advantages for specific applications .
Secretion signals: The N-terminal portion of pre-pro-α-factor is commonly used but can partially lead to protein aggregation. Hybrid secretion signals incorporating S. cerevisiae Ost1 signal sequence paired with α-factor pro region (αPR) have demonstrated higher secretion efficiency for certain proteins .
Selection markers: Traditional markers like Zeocin resistance can be recycled using CRISPR/Cas9 geneticin plasmids. Alternative markers such as acetamidase (amdS) enable effective marker recycling through counter-selection with fluoroacetamide for multi-step genetic engineering .
Integration approach: Single copy vs. multi-copy integration impacts expression levels. Marker-free systems using CRISPR/Cas9 with efficient gRNA targets allow integration of multiple gene cassettes simultaneously .
Several strategies can enhance homologous recombination (HR) efficiency for AIM11 expression in P. pastoris:
Optimizing AIM11 folding and secretion requires addressing several critical parameters:
ER stress management: Recombinant gene overexpression can overwhelm the endoplasmic reticulum (ER), triggering the unfolded protein response (UPR). Co-expression of chaperones and folding-assisting proteins can alleviate ER stress and improve proper protein folding .
Secretion pathway engineering: Manipulation of the vacuolar protein sorting (VPS) system through generation of VPS mutant strains can enhance recombinant protein secretion. The impairment of VRS is considered an effective means of improving secretion efficiency .
Signal sequence optimization: The selection and engineering of secretion signals significantly impacts protein export from the ER. For AIM11, hybrid signals like the S. cerevisiae Ost1 signal sequence paired with the α-factor pro region can offer superior secretion efficiency compared to standard α-factor signal sequences .
Metabolic monitoring: Metabolomic analysis can identify biomarkers indicating cellular stress resulting from the UPR during high expression conditions. These biomarkers can guide process optimization to minimize stress while maximizing protein production .
Temperature and pH optimization: Maintaining optimal temperature and pH conditions during cultivation is essential for proper protein folding and secretion. For AIM11, conditions must be experimentally determined based on protein stability and expression levels.
A comprehensive purification strategy for AIM11 should consider:
Affinity tag selection: His-tagging is commonly employed (as shown in the product specification) for simplified purification using immobilized metal affinity chromatography (IMAC) . The position of the tag (N-terminal vs. C-terminal) may affect protein function and must be validated.
Expression approach selection:
Initial clarification steps:
Centrifugation (6,000-10,000 × g for 15-30 minutes) to remove cells
Filtration through 0.45 μm or 0.22 μm filters
Concentration using tangential flow filtration if expression levels are low
Chromatographic purification sequence:
Storage considerations: Store purified AIM11 in appropriate buffer (e.g., Tris/PBS-based buffer, pH 8.0) with 6% trehalose or 5-50% glycerol to prevent freeze-thaw damage. Aliquot and store at -20°C/-80°C for long-term storage .
Advanced structure-function studies of AIM11 require multiple complementary approaches:
Site-directed mutagenesis strategies:
Protein structural analysis:
Crystallization trials with purified protein for X-ray crystallography
Cryo-EM studies for larger complexes involving AIM11
NMR spectroscopy for dynamic structural information
In silico structural prediction using AlphaFold2 for initial structural hypothesis generation
Functional correlation experiments:
Mitochondrial localization studies using fluorescent protein fusions
Mitochondrial inheritance assays in wild-type vs. AIM11 mutant strains
Protein-protein interaction studies using:
Co-immunoprecipitation
Yeast two-hybrid screening
BioID or APEX2 proximity labeling
Crosslinking mass spectrometry
Biophysical characterization:
Circular dichroism spectroscopy to analyze secondary structure components
Differential scanning calorimetry to assess thermal stability
Isothermal titration calorimetry for binding interactions
Surface plasmon resonance for kinetic binding studies
Balancing high expression with cellular fitness requires sophisticated approaches:
Integration site selection strategies:
Copy number optimization:
Development of a screening system using flow cytometry with fluorescent reporters to identify optimal copy number
qPCR-based quantification of integration events correlated with expression levels and growth characteristics
Implementation of inducible promoter systems allowing fine-tuning of expression levels
Metabolic burden assessment:
Metabolomic analysis to identify bottlenecks and metabolic imbalances
Transcriptomic analysis to evaluate cellular stress responses
Growth rate and recombinant protein productivity measurements in various carbon sources
Mitochondrial function assays given AIM11's role in mitochondrial processes
Genetic stability enhancement:
Codon optimization to reduce ribosomal load
Balancing of copy number with cellular capacity
Application of antibiotic-free selection systems to maintain selective pressure during scale-up
Long-term cultivation stability studies with periodic verification of cassette integrity
Advanced approaches to mitigate ER stress include:
Engineered chaperone networks:
Co-expression of specific chaperones (BiP, PDI, calnexin) under controlled promoters
Implementation of engineered UPR elements to preemptively activate folding machinery
Screening of chaperone combinations for synergistic effects on AIM11 folding
Cultivation process optimization:
Temperature-shift protocols (lowering temperature during induction phase)
Feed rate modulation in bioreactor cultivations to balance growth with protein production
Addition of chemical chaperones (e.g., DMSO, glycerol, betaine) to culture medium
Controlled dissolved oxygen levels to support mitochondrial function
Protein engineering approaches:
Domain-by-domain expression to identify problematic regions
Creation of fusion constructs with highly soluble partners
Implementation of split-intein systems for separate expression and subsequent protein splicing
Directed evolution of AIM11 variants with improved folding properties
Monitoring and responsive systems:
Real-time monitoring of UPR activation using reporter constructs
Implementation of feedback-controlled expression systems responding to cellular stress levels
Integration of metabolomic data with transcriptomic profiles to identify optimal expression windows
Development of mathematical models predicting optimal induction timing based on cellular state
Key experimental design considerations include:
Control selection:
Wild-type AIM11 expression as positive control
Empty vector transformants as negative controls
AIM11 knockout strains for loss-of-function studies
Domain-specific mutants for structure-function analysis
Visualization strategies:
Fluorescent protein tagging (considering tag position effects)
Immunofluorescence with validated antibodies
Live cell imaging compatible with mitochondrial dyes
Super-resolution microscopy for detailed localization studies
Functional assays:
Mitochondrial morphology analysis before and after cell division
Quantitative assessment of mitochondrial inheritance patterns
Mitochondrial membrane potential measurements
Respiratory capacity evaluations using oxygen consumption rates
Interaction studies:
Identification of AIM11 binding partners in mitochondrial membranes
Characterization of protein complexes involving AIM11
Analysis of AIM11 dynamics during cell cycle progression
Evaluation of AIM11 response to cellular stressors
Resolving contradictory data requires systematic experimental approaches:
Source variation assessment:
Expression of AIM11 from different species/strains to identify conserved functions
Comparative analysis of sequence variations and their functional implications
Creation of chimeric proteins to isolate functional domains
Conditional expression systems:
Implementation of regulatable promoters to control expression timing and levels
Temperature-sensitive mutants to allow rapid function modulation
Anchor-away or degron systems for controlled protein depletion
Comprehensive phenotypic analysis:
High-throughput screening under various growth conditions
Metabolomic profiling to identify subtle phenotypic differences
Transcriptomic analysis to detect compensatory mechanisms
Systematic genetic interaction mapping (synthetic lethality/rescue screens)
Experimental validation approach:
Independent validation by multiple research groups
Use of different methodological approaches to test the same hypothesis
Careful control of experimental variables that might explain discrepancies
Meta-analysis of published data to identify patterns in contradictory results
Scaling up AIM11 production requires addressing:
Expression optimization:
Selection between batch, fed-batch, and continuous cultivation strategies
Design of feeding strategies to maintain optimal growth conditions
Implementation of DO-stat or pH-stat control for process consistency
Development of defined media formulations to reduce batch-to-batch variation
Bioreactor parameters:
Optimization of dissolved oxygen levels (30-50%)
pH control strategies (typically pH 5.0-6.0)
Temperature control (typically 28-30°C during growth, potentially lowered to 20-25°C during induction)
Agitation and aeration rates to prevent oxygen limitation while minimizing shear stress
Induction strategy:
For methanol-inducible promoters, development of methanol feeding strategies:
Dissolved oxygen spike method
Programmed feeding based on predicted consumption
Sensor-based adaptive control
Optimizing induction timing based on biomass concentration
Purification scale-up considerations:
Implementation of expanded bed adsorption for direct capture from high-density cultures
Development of continuous chromatography processes
Scale-up of buffer systems and optimization of elution conditions
Implementation of high-throughput screening for crystallization conditions
A systematic optimization approach includes:
sgRNA design optimization:
Cas9 expression optimization:
Delivery method optimization:
Repair pathway manipulation:
Comprehensive analytical validation includes:
Structural integrity assessment:
Circular dichroism spectroscopy to analyze secondary structure content
Intrinsic fluorescence spectroscopy to assess tertiary structure
Size exclusion chromatography to verify monodispersity
Differential scanning calorimetry to determine thermal stability
Limited proteolysis to probe for properly folded domains
Functional verification:
Mitochondrial binding assays using isolated mitochondria
Lipid interaction studies (if membrane association is expected)
ATPase activity assays (if applicable)
Protein-protein interaction studies with known binding partners
Complementation assays in AIM11-deficient yeast strains
Post-translational modification analysis:
Mass spectrometry to identify and quantify modifications
Western blot with modification-specific antibodies
Glycan analysis using lectin binding or specialized chromatography
Phosphorylation site mapping using phospho-specific antibodies
Localization studies:
Subcellular fractionation followed by Western blot analysis
Immunofluorescence microscopy to verify mitochondrial targeting
Electron microscopy with immunogold labeling for precise localization
In vitro mitochondrial import assays to verify targeting sequences functionality